Genesense Hong Kong Limited
PrivateLast Round
Strategic
Sep 13, 2024
Company Overview
Genesense Hong Kong Limited operates in Healthcare & Life Sciences and is based in Hong Kong. Its latest recorded funding round was an Angel round in November 2017.
Genesense Hong Kong Limited is a biotechnology company that develops, transforms, and industrializes new in vitro clinical diagnostic instruments and reagents.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Medical Devices, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genesense Hong Kong Limited Comparables
Compare Genesense Hong Kong Limited with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Singular Genomics | 79% | |
| Qitan Tech | 79% | |
| Element Biosciences | 77% |
For institutional investors. Book with your work email.
Genesense Hong Kong Limited Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Sep 13, 2024 | ||||
| Angel | Nov 1, 2017 |
For institutional investors. Book with your work email.
Genesense Hong Kong Limited Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hong Kong Investment Corporation | Strategic |
| Hong Kong X-Tech Startup Platform | Angel |
| Brizan Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2024
Led by Hong Kong Investment Corporation.
- Nov 1, 2017
Funded by HK X-Technology Fund.
For institutional investors. Book with your work email.
Genesense Hong Kong Limited Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Genesense Hong Kong Limited's valuation, stock price, and market status.
Is Genesense Hong Kong Limited a public or private company?
Genesense Hong Kong Limited is a private company.
What is the current stock price of Genesense Hong Kong Limited?
Genesense Hong Kong Limited is a private company, so its shares have no public market price. Caplight tracks Genesense Hong Kong Limited's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Genesense Hong Kong Limited worth (valuation)?
Valuation information for Genesense Hong Kong Limited is not publicly available.
Can I buy Genesense Hong Kong Limited stock?
Genesense Hong Kong Limited shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Genesense Hong Kong Limited's last funding round?
Genesense Hong Kong Limited's most recent funding round was Strategic on September 13, 2024.
Who are the main investors in Genesense Hong Kong Limited?
Key investors in Genesense Hong Kong Limited include Hong Kong Investment Corporation, Brizan Ventures.
Will Genesense Hong Kong Limited IPO soon?
No public IPO plans have been announced for Genesense Hong Kong Limited.
How can I track Genesense Hong Kong Limited secondary market activity?
Caplight tracks bids, offers, and trades in Genesense Hong Kong Limited's shares on secondary markets.